SCHEMBL18015355

SCHEMBL18015355

Brc1ccccc1-c1ccc(-c2ccccn2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
MAPK1 P28482 2/20 0.54
KDM4E B2RXH2 6/20 0.48
LMNA P02545 4/20 0.48
CYP1A2 P05177 2/20 0.48
CCR1 P32246 2/20 0.48
CCR5 P51681 2/20 0.48
CCR8 P51685 2/20 0.48
POLB P06746 1/20 0.48
METAP1 P53582 1/20 0.48
BLM P54132 1/20 0.48
HIF1A Q16665 1/20 0.48
DOHH Q9BU89 1/20 0.48
P4HTM Q9NXG6 1/20 0.48
DCTPP1 Q9H773 1/20 0.46
CYP2D6 P10635 1/20 0.45
CYP19A1 P11511 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
CYP2A6 P11509 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18015184 0.93 ALDH1A1 (0.47) ALDH1A1MAPK1KDM4ELMNACYP1A2
SCHEMBL18015186 0.93 ALDH1A1 (0.47) ALDH1A1MAPK1KDM4ELMNACYP1A2
SCHEMBL13321322 0.93 ALDH1A1 (0.45) ALDH1A1MAPK1KDM4ELMNACYP1A2
SCHEMBL7707483 0.85 MAPK1 (0.50) ALDH1A1MAPK1KDM4ELMNACYP1A2
SCHEMBL758869 0.85 MAPK1 (0.50) ALDH1A1MAPK1KDM4ELMNACYP1A2
SCHEMBL760818 0.85 MAPK1 (0.50) ALDH1A1MAPK1KDM4ELMNACYP1A2
SCHEMBL21662368 0.85 GRM5 (0.42) ALDH1A1MAPK1KDM4ECCR1CCR5
SCHEMBL21742890 0.84 MAPK1 (0.48) ALDH1A1MAPK1KDM4ELMNACYP1A2
SCHEMBL29765883 0.84 KDM4E (0.56) ALDH1A1MAPK1KDM4ELMNACYP1A2
SCHEMBL750980 0.84 KDM4E (0.56) ALDH1A1MAPK1KDM4ELMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12635401-B2 Metal complexes UDC Ireland (IE) 2026-05-19 US disclosed
US-12402523-B2 Metal complexes UDC IRELAND LIMITED (IE) 2025-08-26 US disclosed
EP-4069709-B1 METAL COMPLEXES UDC IRELAND LTD (IE) 2025-04-23 EP disclosed
US-20250115630-A1 METAL COMPLEXES UDC IRELAND LTD (IE) 2025-04-10 US disclosed
US-12180233-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-12-31 US disclosed
CN-114787173-B Metal complex UDC爱尔兰有限公司 2024-10-18 CN disclosed
CN-111699192-B Metal complex UDC爱尔兰有限公司 2024-03-08 CN disclosed
CN-110959010-B Metal complex UDC爱尔兰有限公司 2024-01-23 CN disclosed
US-20230320191-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2023-10-05 US disclosed
US-11659763-B2 Metal complexes MERCK PATENT GMBH 2023-05-23 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-07-04 US disclosed
WO-2018069197-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2018-04-19 WO disclosed
WO-2018069196-A1 BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES MERCK PATENT GMBH (DE) 2018-04-19 WO disclosed
WO-2018054798-A1 BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-03-29 WO disclosed
WO-2018041769-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-03-08 WO disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
WO-2017032439-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-03-02 WO disclosed
WO-2016124304-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES PARN, PUF60, PARG ALDH1A1 3712/4885MAPK1 4579/4885KDM4E 4048/4885
US-12180233-B2 Metal complexes IMMT, MCU, SOD1 ALDH1A1 1473/4885MAPK1 4683/4885KDM4E 4470/4885
US-12635401-B2 Metal complexes SCO2, SOD1, NR4A1 ALDH1A1 2069/4885MAPK1 3126/4885KDM4E 3445/4885
US-20250115630-A1 METAL COMPLEXES IMMT, MCU, SOD1 ALDH1A1 1473/4885MAPK1 4683/4885KDM4E 4470/4885
US-20230320191-A1 METAL COMPLEXES IMMT, MCU, SOD1 ALDH1A1 1473/4885MAPK1 4683/4885KDM4E 4470/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 ALDH1A1 2597/4885MAPK1 4164/4885KDM4E 3864/4885
US-11659763-B2 Metal complexes IMMT, MCU, SOD1 ALDH1A1 1473/4885MAPK1 4683/4885KDM4E 4470/4885
US-12402523-B2 Metal complexes IMMT, MCU, SOD1 ALDH1A1 1473/4885MAPK1 4683/4885KDM4E 4470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.